• News
  • North America

Aevius Launches With $22 Million in Funding

Mass General Brigham spinout raises $22 million led by Insight Partners

11/17/2026
•Ghita Khalfaoui
Back to News

Aevius, a clinical intelligence company, launched with $22 million in funding led by Insight Partners. The Mass General Brigham spinout turns fragmented medical data into actionable insights. It serves health systems, payers, and life sciences companies.


Investor backing

Insight Partners is a global AI and software investor. The firm has more than $90 billion in assets under management. It has invested in over 900 companies worldwide.

Founding background

Aevius was founded by Rowland Pettit, Ming Yang (Max) Lu, Faisal Mahmood, and Long Phi Le. The founders previously helped build Modella AI, which AstraZeneca acquired. They are applying that experience to broader medical data challenges.

How the platform works

Aevius AI models learn from structured, unstructured, and specialty multimodal medical data. They create a refreshable representation of a patient's clinical state and trajectory. Organizations can use that representation to forecast outcomes and monitor change over time.


The company plans to expand its engineering, clinical, and commercial teams. It will continue model and product development. It also plans commercial deployment.